Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly and Incyte Corporation have gotten positive opinion from European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
Eli Lilly and Company and Incyte Corporation have announced on Wednesday that new data from RA-BEACON – a pivotal phase 3 study…
Eli Lilly and Company and Incyte Corporation have announced detailed data from the pivotal phase 3 RA-BEGIN study, which show…
Eli Lilly and Company and Incyte Corporation announced positive topline results of RA-BEAM, the fourth successful Phase 3 study of baricitinib, an investigational medicine for patients with moderately-to-severely active rheumatoid arthritis.